1. Home
  2. PLAY vs ELDN Comparison

PLAY vs ELDN Comparison

Compare PLAY & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dave & Buster's Entertainment Inc.

PLAY

Dave & Buster's Entertainment Inc.

HOLD

Current Price

$6.67

Market Cap

357.3M

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$2.53

Market Cap

291.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLAY
ELDN
Founded
1982
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
357.3M
291.8M
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
PLAY
ELDN
Price
$6.67
$2.53
Analyst Decision
Buy
Strong Buy
Analyst Count
6
2
Target Price
★ $23.83
$8.50
AVG Volume (30 Days)
★ 3.1M
899.1K
Earning Date
06-09-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 30.67
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.57
N/A
Revenue Next Year
$5.00
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.38
$1.35
52 Week High
$22.10
$4.60

Technical Indicators

Market Signals
Indicator
PLAY
ELDN
Relative Strength Index (RSI) 35.08 29.58
Support Level $6.45 $1.96
Resistance Level $10.81 $3.18
Average True Range (ATR) 0.49 0.16
MACD -0.02 0.01
Stochastic Oscillator 11.26 0.88

Price Performance

Historical Comparison
PLAY
ELDN

About PLAY Dave & Buster's Entertainment Inc.

Dave & Buster's Entertainment Inc is an owner and operator of entertainment and dining venues in North America that offer experiences for both adults and families under the Dave & Buster's and Main Event brands. The company combines various forms of entertainment, including games, bowling, and watching live sports and other televised events, with a full menu of entrees and appetizers and a selection of alcoholic and non alcoholic beverages, all in one location. Its concept focuses on providing customers the opportunity to Eat, Drink, Play, and Watch, appealing to a balanced mix of adults, families, and teenagers. The company also operates internationally in the early stage as a franchisor of the Dave & Buster's brand.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: